{"id":"W2110410873","doi":"10.1158/1078-0432.ccr-08-0524","title":"A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":239,"is_retracted":false,"has_abstract":true,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Carcinoembryonic antigen; Antibody; Medicine; Cancer; Antigen; Oncolytic adenovirus; Toxicity; Internal medicine; Virology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005354637,0.0006595763,0.00114153,0.0001319821,0.0002349899,0.0004858891,0.0003798619,0.0005437715,0.001226281],"category_scores_gemma":[0.000482966,0.0002373925,0.0005245709,0.000206375,0.000494657,0.0003419914,0.0001555396,0.001586297,0.000314197],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004732585,"about_ca_system_score_gemma":0.0007505045,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004544742,"about_ca_topic_score_gemma":0.0007492708,"domain_scores_codex":[0.9997916,0.00009202291,0.000008605119,0.00004161269,0.00002547631,0.00004069473],"domain_scores_gemma":[0.9996604,0.00009274558,0.00007075212,0.00004280498,0.00001929101,0.0001139668],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2492309,0.0504164,0.02223477,0.001164147,0.0008039378,0.0008644976,0.0006027711,0.009452241,0.3400658,0.000454177,0.003020828,0.3216896],"study_design_scores_gemma":[0.1221022,0.8061945,0.02611951,0.00005731776,0.0003962529,0.001710819,0.0001004117,0.00406401,0.0321794,0.0002454271,0.006792584,0.00003752679],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955283,0.001726944,0.0009588255,0.0001075036,0.00004182076,0.0006983568,0.0001719308,0.00005315755,0.0007132058],"genre_scores_gemma":[0.9941643,0.001120036,0.002463309,0.00022314,0.00006297885,0.000776038,0.0005998513,0.00001898335,0.0005714791],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001226281,"threshold_uncertainty_score":0.00410229,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1555367822917899,"score_gpt":0.5162728224528756,"score_spread":0.3607360401610858,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}